Zentalis Pharmaceuticals, Inc. - ZNTL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Chief Medical Officer | S | D | 335.0 | 2.3929 | 801.62 | 33,332.0 | View | |
| Feb 10, 2026 | Chief Medical Officer | S | D | 2,962.0 | 2.4297 | 7,196.77 | 33,667.0 | View | |
| Feb 10, 2026 | PAO and PFO | S | D | 6,894.0 | 2.4223 | 16,699.34 | 146,506.0 | View | |
| Feb 10, 2026 | PAO and PFO | S | D | 3,379.0 | 2.3929 | 8,085.61 | 153,400.0 | View | |
| Feb 10, 2026 | PAO and PFO | S | D | 29,951.0 | 2.4297 | 72,771.94 | 156,779.0 | View | |
| Feb 10, 2026 | CEO & President | S | D | 889.0 | 2.3929 | 2,127.29 | 79,133.0 | View | |
| Feb 10, 2026 | CEO & President | S | D | 7,866.0 | 2.4297 | 19,112.02 | 80,022.0 | View | |
| Feb 04, 2026 | PAO and PFO | S | D | 556.0 | 2.515 | 1,398.34 | 186,730.0 | View | |
| Feb 04, 2026 | PAO and PFO | S | D | 2,540.0 | 2.55 | 6,477.0 | 187,286.0 | View | |
| Jan 09, 2026 | PAO and PFO | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jan 09, 2026 | Chief Legal Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jan 09, 2026 | Chief Medical Officer | A | A | 365,000.0 | 0.0 | 0.0 | 365,000.0 | View | |
| Jan 09, 2026 | CEO & President | A | A | 775,000.0 | 0.0 | 0.0 | 775,000.0 | View | |
| Jan 08, 2026 | — | P | A | 6,459,973.0 | 1.2 | 7,751,967.6 | 13,509,973.0 | View | |
| Dec 15, 2025 | — | S | D | 7,500,000.0 | 1.33 | 9,975,000.0 | 6,459,973.0 | View |